January 4, 2024 · Form 4 insider transaction
Mirviss Jeffrey B. sold 15,000 shares of Boston Scientific Corporation at $58.40 per share, a transaction worth $876.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan adopted on May 25, 2023.; Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $58.40 to $58.405, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.